SAM VAFADAR: Open Payments
NPI 1093152407 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,686 in 15 payments from 6 companies in 2025. Trend: 2023 $2,755 · 2024 $132 · 2025 $6,686
Travel & lodging: $5,760Food & beverage: $926
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 8 | $6,008 |
| Janssen Biotech, Inc. | 2 | $206 |
| Regeneron Healthcare Solutions, Inc. | 2 | $202 |
| Daiichi Sankyo Inc. | 1 | $138 |
| AstraZeneca Pharmaceuticals LP | 1 | $114 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: DATROWAY, RYBREVANT, LIBTAYO, OPDIVO.
Industry payments across FL — which companies pay providers there.
